Related Experiment Videos
[Skeletal changes in intermediate beta-thalassemia. Clinical and radiological study]
Minerva Medica
|March 3, 1982
Summary
Beta-thalassaemia intermedia carriers can exhibit bone changes similar to homozygous forms, though less severe. Clinical symptoms range from mild anemia and red blood cell abnormalities to severe Cooley's anemia.
Area of Science:
- Hematology
- Orthopedics
- Genetics
Background:
- Beta-thalassaemia intermedia is a genetic blood disorder.
- It presents a spectrum of clinical severity.
- Bone complications are a known, but variable, feature.
Purpose of the Study:
- To describe bone changes in carriers of beta-thalassaemia intermedia.
- To correlate skeletal findings with clinical and hematological parameters.
- To understand the variability in presentation.
Main Methods:
- Observational study of 10 carriers.
- Clinical examination.
- Skeletal assessment (skull, ribs, hands, elbows, knees).
- Hematological parameter analysis (hemoglobin levels, red blood cell morphology).
Main Results:
- Bone changes were observed in various skeletal sites.
- Skeletal changes resembled homozygous beta-thalassaemia but were less pronounced.
- Common symptoms included mild anemia (Hb 6-11 g/dl), altered red blood cells, splenomegaly, jaundice, gallstones, and leg ulcers.
- Clinical presentation varied from asymptomatic to severe Cooley's anemia.
Conclusions:
- Beta-thalassaemia intermedia carriers can develop significant bone abnormalities.
- Skeletal manifestations are generally milder than in homozygous beta-thalassaemia.
- Clinical and skeletal phenotypes exhibit considerable heterogeneity.